 MIAMI, Jan. 26, 2022 GLOBE NEWSWIRE -- Veru Inc. NASDAQ: VERU, an oncology biopharmaceutical company with a focus on developing novel medicines for the management of breast and prostate cancer, today announced that it will report financial results for its fiscal 2022 first quarter, on Wednesday, February 9, 2022, before the market opens. Verus management will host a conference call that same day at 8 a.m. ET to review the Companys performance and to answer questions. The call will also be accessible via webcast. 